Occidental Asset Management’s Mateon Therapeutics MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-10,000
Closed -$6K – 139
2016
Q3
$6K Hold
10,000
– – ﹤0.01% 94
2016
Q2
$7K Buy
+10,000
New +$7.08K 0.01% 96

Other funds holding MATN

Occidental Asset Management's MATN Position: Q4 2016 in Review

Occidental Asset Management sold out of Mateon Therapeutics (MATN) in Q4 2016, closing a stake of 10,000 shares — an estimated $6K sold.

Occidental Asset Management first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $7K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Occidental Asset Management reported no remaining Mateon Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Occidental Asset Management sold 10,000 Mateon Therapeutics shares in Q4 2016, an estimated $6K.
  • Occidental Asset Management first reported a position in Mateon Therapeutics in Q2 2016 and held it in 2 quarters.
  • Occidental Asset Management's Mateon Therapeutics position peaked at $7K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics as of Q4 2016.

Based on Occidental Asset Management's 13F filing for Q4 2016, filed 15 May 2019.